🇺🇸 durolane in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 20

Most-reported reactions

1. Drug Ineffective — 4 reports (20%)
2. Arthralgia — 3 reports (15%)
3. Pain — 3 reports (15%)
4. Musculoskeletal Pain — 2 reports (10%)
5. Pain In Extremity — 2 reports (10%)
6. Rheumatoid Arthritis — 2 reports (10%)
7. Anaemia — 1 report (5%)
8. Arthritis — 1 report (5%)
9. Arthropathy — 1 report (5%)
10. Asthma — 1 report (5%)

Source database →

Frequently asked questions

Is durolane approved in United States?

durolane does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for durolane in United States?

Assistance Publique Hopitaux De Marseille is the originator. The local marketing authorisation holder may differ — check the official source linked above.